These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27097966)

  • 1. Sublingual sufentanil, a new opportunity for the improvement of postoperative pain management in Italy.
    Sacerdote P; Coluzzi F; Fanelli A
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1411-22. PubMed ID: 27097966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of sublingual sufentanil for postoperative pain management.
    van de Donk T; Ward S; Langford R; Dahan A
    Anaesthesia; 2018 Feb; 73(2):231-237. PubMed ID: 29219169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sufentanil sublingual tablet system vs. intravenous patient-controlled analgesia with morphine for postoperative pain control: a randomized, active-comparator trial.
    Melson TI; Boyer DL; Minkowitz HS; Turan A; Chiang YK; Evashenk MA; Palmer PP
    Pain Pract; 2014 Nov; 14(8):679-88. PubMed ID: 25155134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sufentanil sublingual tablet system for the management of postoperative pain.
    Babazade R; Turan A
    Expert Opin Pharmacother; 2016 Dec; 17(17):2351-2357. PubMed ID: 27796147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic evaluation of sublingual sufentanil in the treatment of post-operative pain.
    Babazade R; Turan A
    Expert Opin Drug Metab Toxicol; 2016; 12(2):217-24. PubMed ID: 26799508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sufentanil sublingual formulation for the treatment of acute, moderate to severe postoperative pain in adult patients.
    Porela-Tiihonen S; Kokki M; Kokki H
    Expert Rev Neurother; 2017 Feb; 17(2):101-111. PubMed ID: 27835931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic properties of single- and repeated-dose sufentanil sublingual tablets in healthy volunteers.
    Willsie SK; Evashenk MA; Hamel LG; Hwang SS; Chiang YK; Palmer PP
    Clin Ther; 2015 Jan; 37(1):145-55. PubMed ID: 25544247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An up-to-date overview of sublingual sufentanil for the treatment of moderate to severe pain.
    Porela-Tiihonen S; Kokki H; Kokki M
    Expert Opin Pharmacother; 2020 Aug; 21(12):1407-1418. PubMed ID: 32486875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sufentanil Sublingual Tablet: A New Option for Acute Pain Management.
    Reardon CE; Kane-Gill SL; Smithburger PL; Dasta JF
    Ann Pharmacother; 2019 Dec; 53(12):1220-1226. PubMed ID: 31280585
    [No Abstract]   [Full Text] [Related]  

  • 10. A review of sufentanil and the sufentanil sublingual tablet system for acute moderate to severe pain.
    Minkowitz HS
    Pain Manag; 2015; 5(4):237-50. PubMed ID: 26088280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of sublingual sufentanil tablets and efficacy and safety in the management of postoperative pain.
    Minkowitz HS; Singla NK; Evashenk MA; Hwang SS; Chiang YK; Hamel LG; Palmer PP
    Reg Anesth Pain Med; 2013; 38(2):131-9. PubMed ID: 23271030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of sublingual sufentanil nanotabs for pain relief.
    Minkowitz HS; Candiotti K
    Expert Opin Drug Deliv; 2015 May; 12(5):845-51. PubMed ID: 25388859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sufentanil Sublingual Tablet System: from rationale of use to clinical practice.
    Vergari A; Cortegiani A; Rispoli M; Coluzzi F; Deni F; Leykin Y; Luca Lorini F; Martorano PP; Paolicchi A; Polati E; Scardino M; Corcione A; Giarratano A; Rossi M
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11891-11899. PubMed ID: 33275260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sufentanil 30 µg Sublingual Tablet: A Review in Acute Pain.
    Deeks ED
    Clin Drug Investig; 2019 Apr; 39(4):411-418. PubMed ID: 30887417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingual Sufentanil Tablet System Versus Continuous Morphine Infusion for Postoperative Analgesia in Cardiac Surgery Patients.
    Van Tittelboom V; Poelaert R; Malbrain MLNG; La Meir M; Staessens K; Poelaert J
    J Cardiothorac Vasc Anesth; 2021 Apr; 35(4):1125-1133. PubMed ID: 32951999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dose-finding study of sufentanil sublingual microtablets for the management of postoperative bunionectomy pain.
    Singla NK; Muse DD; Evashenk MA; Palmer PP
    J Trauma Acute Care Surg; 2014 Sep; 77(3 Suppl 2):S198-203. PubMed ID: 25159356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sufentanil sublingual tablets (Zalviso°) and postoperative analgesia.
    Prescrire Int; 2017 May; 26(182):117-118. PubMed ID: 30730666
    [No Abstract]   [Full Text] [Related]  

  • 18. Sublingual Sufentanil: A Review in Acute Postoperative Pain.
    Frampton JE
    Drugs; 2016 Apr; 76(6):719-29. PubMed ID: 27067596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid receptor A118G polymorphism does not affect the consumption of sufentanil and ropivacaine by patient-controlled epidural analgesia after cesarean section.
    Xu GH; Gao M; Sheng QY; Liu XS; Gu EW
    Ther Drug Monit; 2015 Feb; 37(1):53-7. PubMed ID: 24977380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic Properties of a Sufentanil Sublingual Tablet Intended to Treat Acute Pain.
    Fisher DM; Chang P; Wada DR; Dahan A; Palmer PP
    Anesthesiology; 2018 May; 128(5):943-952. PubMed ID: 29498947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.